EconomyGSK and Moderna settle patent dispute over COVID-19 and RSV shots

British drugmaker GSK and Moderna said Friday they had settled lawsuits accusing Moderna’s COVID-19 vaccines Spikevax and mNEXSPIKE, along with its RSV shot mResvia, of infringing GSK patents.

drugmakerspatent disputeCOVID-19 vaccinesRSV

RReuters★★☆☆☆2026-11-06 18:25Original